Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.

Cancer immunology, immunotherapy : CII - 1 Mar 2023

Wu Peng, Zhang Zhihui, Yang Zhaoyang, Zhang Chaoqi, Luo Yuejun, Zhang Guochao, Wang Lide, Xue Qi, Sun Nan, He Jie

Abstract excerpt

Owing to the paucity of specimens, progress in identifying prognostic and therapeutic biomarkers for small cell lung cancer (SCLC) has been stagnant for decades. Considering that the costimulatory molecules are essential elements in modulating immune responses and determining therapeutic response, we systematically revealed the expression landscape and identified a costimulatory molecule-based signature (CMS) to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Share to Small Cell Lung Carcinoma

Share to Transcription Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 36002754
DOI: 10.1007/s00262-022-03280-8
PMCID: PMC9947026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer.PMID 36002754Read ↗

Costimulatory Molecule Expression Profile as a Biomarker to Predict Prognosis and Chemotherapy Response for Patients With Small-cell Lung CancerSemantic proximity Read ↗

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinomaSemantic proximity Read ↗

Integrative analysis of multi‐omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancerSemantic proximity Read ↗

An Immune-related Lncrna Signature Predicts Prognosis and Adjuvant Chemotherapeutic Response in Patients With Small-cell Lung CancerSemantic proximity Read ↗

A signature based on costimulatory molecules for the assessment of prognosis and immune characteristics in stomach adenocarcinomaSemantic proximity Read ↗

Identification of a Novel Costimulatory Molecule-Related Signature to Predict Prognostic Risk and Immunotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

Constructing a Prognostic Model for Non-Small-Cell Lung Cancer Risk Based on Genes Characterising the Differentiation of Myeloid-Derived Suppressor CellsSemantic proximity Read ↗

Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation.Semantic proximity Read ↗

Construction of an immunogenic cell death related gene signature: A new prognostic model for small cell lung cancerSemantic proximity Read ↗

CCL5 as a Prognostic Marker for Survival and an Indicator for Immune Checkpoint Therapies in Small Cell Lung CancerSemantic proximity Read ↗

AC099850.3 Promotes Cell Proliferation and is One of Five Costimulatory Molecule-Related LncRNAs That Predict Overall Survival of Liver Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and Validation a Costimulatory Molecule Gene Signature to Predict the Prognosis and Immunotherapy Response for Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.